Boiron’s Oscillo
January 2017: After a trial, judgment was entered in favor of the company because the plaintiff failed to prove that the company’s representations were false, misleading, or likely to deceive…
Dickerson et al. v. Boiron, Inc.
23-cv-2370, C.D. Cal.
(Nov. 2023)
Optique1 Eye Drops
Falsely marketing that products are “Homeopathic Medicine” that provide relief from eye irritation, dry eyes, allergies, and eye strain when they do not provide the advertised relief
Pending
January 2017: After a trial, judgment was entered in favor of the company because the plaintiff failed to prove that the company’s representations were false, misleading, or likely to deceive…
In February 2015, a federal appellate court upheld a $5 million settlement of a false advertising class-action lawsuit filed against Boiron, Inc., maker of a variety of homeopathic products, in…
Why these products may leave you wanting more.
Class-action lawsuits target preservative-free claims.
Revenge is Sweet
This company may need to cleanse its marketing tactics.
A closer look at what we’ll be monitoring in the new year.